Cell therapy could be a potential way to improve lipoprotein lipase deficiency

BACKGROUND: Lipoprotein lipase (LPL) deficiency is an autosomal recessive genetic disorder characterized by extreme hypertriglyceridemia, with no cure presently available. The purpose of this study was to test the possibility of using cell therapy to alleviate LPL deficiency. METHODS: The LPL coding...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wenjing, Yin, Yajun, Zhong, Jie, Peng, Yongjia, Li, Shuncai, Zheng, Libin, Cao, Hong, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625700/
https://www.ncbi.nlm.nih.gov/pubmed/28969646
http://dx.doi.org/10.1186/s12944-017-0577-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625700/
https://www.ncbi.nlm.nih.gov/pubmed/28969646
http://dx.doi.org/10.1186/s12944-017-0577-4

Ejemplares similares